>>> Humana beats by $0.04; guides Q3 EPS in-line; reaffirms FY15 EPS guidance; a

Humana beats by $0.04; guides Q3 EPS in-line; reaffirms FY15 EPS guidance; as previously announced, being acquired by AET

Reports Q2 (Jun) earnings of $1.67 per share, $0.04 better than the Capital IQ Consensus Estimate of $1.63.
  • Co issues in-line guidance for Q3, sees EPS of $2.15 vs. $2.16 Capital IQ Consensus Estimate.
  • Co reaffirms guidance for FY15, sees EPS of $7.75 vs. $7.77 Capital IQ Consensus Estimate.
  • On July 3, 2015, the company announced it entered into a definitive agreement with Aetna Inc. (AET) under which Aetna will acquire all outstanding shares of Humana for a combination of cash and stock. Under terms of the agreement, Humana stockholders will receive $125 in cash and 0.8375 of an Aetna common share for each Humana share.